Urine Cytology Adds Little to Hematuria Investigation In most responders, overactive bladder symptom improvement sustained to three years. Percutaneous tibial nerve stimulation with the Urgent PC ...

Overactive bladder (OAB) is defined as urinary urgency, with or without urge incontinence, often with frequency and nocturia. Initial therapy of OAB often includes anticholinergics and behavioral ...

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children ...

Percutaneous tibial nerve stimulation may be considered an alternative treatment for overactive bladder (OAB), researchers reported in the Journal of Urology (2009;182:1055-1061). Kenneth M. Peters, ...

Oct. 28, 2005 — The U.S. Food and Drug Administration (FDA) has approved a total-body dual-energy x-ray absorptiometry system for use as an aid in the detection and diagnosis of osteoporosis, and for ...

NeurAxis, Inc. has announced new medical policy coverage for its Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, specifically the IB-Stim device, by two health insurers in ...

The FDA has granted De Novo clearance to a prescription nerve stimulation device for the reduction of functional abdominal pain. The device is intended for use by adolescents and teens with irritable ...

Electrical stimulation was delivered by an external stimulator (top left) through percutaneous leads to FINEs implanted on the median, ulnar, and radial nerves of an upper-limb amputee (bottom left).

Targeting a single nerve promotes healing in rats with chronic intestinal inflammation. Can the same strategy work in humans?

A percutaneous rhizotomy is a minimally invasive procedure to treat trigeminal neuralgia. Our surgeons use a small needle to make a controlled, minor injury to one of your facial nerves (your ...

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...